Valuation: Uscom Limited

Market Cap 3.12M 2.16M 1.93M 1.79M 1.63M 3.07M 205M 21.52M 8.42M 107M 8.11M 7.93M 342M P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 4.42M 3.06M 2.73M 2.54M 2.31M 4.34M 290M 30.47M 11.92M 151M 11.47M 11.23M 483M EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
3 years 0.01
Extreme 0.011
0.05
5 years 0.01
Extreme 0.011
0.14
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 2011-03-06
Corporate Secretary 66 2016-05-23
Corporate Officer/Principal - 2018-05-27
Director TitleAgeSince
Chairman - 2009-10-31
Director/Board Member 66 2018-08-22
Director/Board Member 62 2019-12-15
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%-.--%-76.00% 2.17M
+3.46%+5.20%+32.46%+44.25% 249B
+3.03%+5.95%+12.30%+10.54% 158B
+1.81%+3.22%-1.95%+56.64% 148B
+2.65%+6.16%-54.14%-10.86% 62.32B
+1.95%+5.94%-12.00%-14.04% 49.61B
+1.91%+2.70%+20.09%+24.47% 49.83B
+5.27%+10.81%+8.82%+44.85% 48.14B
+0.89%+3.82%+27.17%+58.85% 49.06B
+1.73%+1.87%+33.32%+75.82% 42.9B
Average +3.00%+1.98%+6.61%+21.45% 85.72B
Weighted average by Cap. +2.43%+1.95%+11.61%+34.10%

Financials

2024 2025
Net sales 3.73M 2.58M 2.3M 2.14M 1.95M 3.66M 244M 25.7M 10.05M 127M 9.68M 9.47M 408M 2.58M 1.78M 1.59M 1.48M 1.35M 2.53M 169M 17.78M 6.96M 88.17M 6.7M 6.55M 282M
Net income -2.07M -1.44M -1.28M -1.19M -1.08M -2.04M -136M -14.31M -5.6M -70.94M -5.39M -5.27M -227M -3.3M -2.29M -2.04M -1.9M -1.72M -3.24M -216M -22.77M -8.91M -113M -8.58M -8.39M -361M
Net Debt -1.53M -1.06M -945K -879K -799K -1.5M -100M -10.55M -4.13M -52.34M -3.97M -3.89M -167M 1.3M 897K 801K 745K 677K 1.27M 85M 8.94M 3.5M 44.35M 3.37M 3.3M 142M
Projected Income Statement - Annual - Uscom Limited
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35